Navigation Links
More Than 300 New Medicines Being Developed for Mental Illnesses
Date:7/24/2008

NEW ORLEANS, July 24 /PRNewswire-USNewswire/ -- There are a record 301 new medicines being developed for mental illnesses, according to a new report released here today during a briefing that focused on the devastating effects that mental illnesses have on patients, their families, and society. Nationwide, mental illness affects nearly 60 million American adults. The briefing, led by the Pharmaceutical Research and Manufacturers of America (PhRMA), featured Emmy Award-winning actor Joey Pantoliano -- well known for his role in The Sopranos -- who suffers from depression.

In Louisiana, rates of post-traumatic stress disorder and suicide have increased since hurricanes Katrina and Rita, according to the National Institute on Drug Abuse. Mental disorders after a natural disaster usually decrease with time, with about 50 percent of post-traumatic mental disorders resolved within a year of the disaster, notes a recent Harvard University study. However, in the case of Hurricane Katrina, the researchers found the contrary: Anxiety or mood disorder has been increasing by 30 percent and more.

"We are releasing this report in Louisiana in view of the upcoming third anniversary of Hurricane Katrina and the state's continuing need for assistance in treating mental illness," said PhRMA Senior Vice President Ken Johnson. "The medicines being developed treat a range of conditions, from depression to anxiety, and from schizophrenia to dependence on alcohol and drugs. These medicines are either in clinical trials or awaiting review by the U.S. Food and Drug Administration, and they will help patients live longer, happier, and healthier lives. It's important for patients and healthcare providers to know that research into mental illness remains a top priority."

Many of these diseases, such as depression, were once misunderstood causes of shame and fear. Fortunately, today many are highly treatable conditions.

Unfortunately, despite the tremendous progress, mental illness continues to exact a heavy human and economic toll in this country. According to the National Institute of Mental Health, the total cost (direct and indirect) of treating mental illnesses in the United States is $205 billion a year.

Included in the report's new medicines in the research pipeline are: 66 medicines for depression, which affects nearly 21 million Americans; 26 medicines for addictive disorders, including dependence on alcohol, tobacco or illicit drugs; 54 medicines for anxiety disorders, which affect more than 40 million adults ages 18 and older; 89 for dementias, including Alzheimer's disease, which affects more than 5 million Americans; and 45 for schizophrenia, which strikes some 2.4 million adults each year.

"Patients and healthcare providers need to know that there are many new, potential options out there that could allow them a better quality of life," said Pantoliano. "Instead of suffering in silence and isolating themselves, as I did for many years, I encourage everyone with a mental illness -- or who thinks they may have a mental illness -- to find out what the options are and seek treatment. People who are suffering need to know that there is hope."

Joey Pantoliano is one of the best-known character actors in Hollywood, appearing in more than 100 movies and television shows. But he is probably best known for his critically acclaimed and Emmy award-winning performance as psychopathic mobster Ralphie Cifaretto on The Sopranos. His lengthy movie credits include Risky Business, The Matrix, The Fugitive, U.S. Marshals, Bad Boys, Empire of the Sun, Running Scared and The Goonies. In his most recent film, Canvas, Pantoliano plays a husband trying to hold his family together while his wife, portrayed by Oscar-winning actress Marcia Gay Harden, battles schizophrenia. Making the film helped Pantoliano come to terms with his own depression, a condition he revealed he has been suffering from for more than a decade. Rather than hide his struggle from the public, Pantoliano has chosen to speak out about his disease, and founded the organization "No Kidding, Me Too!" (http://www.nkm2.org) to help remove the isolation and stigma that often surrounds mental illness.

Johnson stressed that while researchers are making exciting progress in the search for new cures and treatments for mental health disorders, these efforts are wasted if the medicines that are developed are not accessible to the patients who need them.

Help is available to patients in need through the Partnership for Prescription Assistance (PPA), a program sponsored by America's pharmaceutical research companies. To date, the PPA has helped more than 5 million patients nationwide, including more than 119,000 people in Louisiana. Since its launch in April 2005, the PPA bus tour has visited all 50 states and more than 2,000 cities. The PPA bus has been to Louisiana seven times since the program was launched.

To read the 2008 report, Medicines in Development for Mental Illnesses on the PhRMA Web site, go to: http://www.phrma.org.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.

PhRMA Internet Address: http://phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://innovation.org

For information on the Partnership for Prescription Assistance, visit: http://pparx.org

For information on the danger of imported drugs, visit: http://buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
2. European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
3. Report on 750 New Medicines in Development for Cancer Released in Baton Rouge
4. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
5. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
6. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
7. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
8. 92 Medicines and Vaccines now in Development for HIV/AIDS
9. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/12/2017)... , June 12, 2017 Kineta, Inc., a biotechnology ... Kineta Vice President of R&D and Head of ... Pandemic Preparedness for the Northwest and Beyond meeting ... on June 14, 2017 from 8:30-10:30 AM PDT at the ... Dr. Bedard will be joined by other ...
(Date:6/8/2017)... MAITLAND, Fla. , June 8, 2017  Less ... ransomware attack that hit more than 200,000 companies, including hospital ... is being heralded as one of the largest online ... technology in the healthcare market, it is imperative that ... can protect their data from this — and many ...
Breaking Medicine Technology:
(Date:6/23/2017)... , ... June 23, 2017 , ... Everybody has their ... while others prefer to read it, and some people don't like it at all. ... Here's what they found: , Erotic literature can give readers a taste of their ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South Asia Leaders Selected ... from government, business and civil society in 11 countries across the Middle East and ... in a transformative exchange of knowledge and ideas with the leading minds in their ...
(Date:6/23/2017)... ... 23, 2017 , ... Ulster University, Magee Campus in Northern Ireland is hosting ... pm to present to graduate students exciting new and innovative hope research based on ... by The Health Improvement Service of the Western Health & Social Care Trust (WHSCT) ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
Breaking Medicine News(10 mins):